U.S. Markets close in 6 hrs 20 mins

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2018, after the close of the market and host a conference call at 4:30pm Eastern Time on Monday, March 18.

Monday, March 18, 2019, at 4:30 PM ET
Domestic:   877-407-0784
International:   201-689-8560
Conference ID:   13687103
Webcast:   http://public.viavid.com/index.php?id=133091
     
Replays available through April 1st:
Domestic:   844-512-2921
International:   412-317-6671
Replay PIN:   13687103


About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:

Media Inquiries:
ARPR, on behalf of iCAD, Inc.
Paul Barren
(855) 300-8209
paul@arpr.com

or

Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com